Shahbazi F, Mirtorabi S, Ghadirzadeh M, Ghoreishi S, Hashemi Nazari S. Epidemiological Study of Mortality from drug Abuse in
Bodies Referred to Iranian Legal Medicine Organization in 2013-2014
. irje 2018; 14 (1) :9-18
URL:
http://irje.tums.ac.ir/article-1-5960-en.html
1- MSc Candidate of Epidemiology, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran
3- Associate Professor of Epidemiology, Safety Promotion and Injury Prevention Research Center, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran , Saeedh_1999@yahoo.com
Abstract: (6496 Views)
Background and Objectives: Drug abuse is one of the medical, social, economic and cultural problems in the present era that increases the morbidity, mortality, and disability among addicts. Iran, due to its adjacency to major centers of opiate drugs production, has a severe and critical condition. Therefore, epidemiological studies are essential for comprehensive management of drug abuse disorders.
Methods: In this descriptive cross-sectional study, demographic and epidemiological data of all people whose cause of death was drug abuse in 2013-14 (1392 Hijri) were extracted by two checklists. Data were then analyzed with SPSS software.
Results: A total of 2957 deaths occurred during the study period. Most deaths occurred in unmarried young males with a low income and education level. The mean age of the subjects was 36.6 12.81 years. The mortality rate from opiate and psychoactive abuse in the whole country was 53.28 in 1000000 population. The most commonly used drugs in the study population were opium, crystal, and heroin in a descending order. Hamedan, Lorestan, and Zanjan provinces with a mortality rate of 150, 101, and 80.06 per 1,000,000 people had the highest mortality due to drug abuse.
Conclusion: Training programs and harm reduction approaches such as methadone treatment and naloxone distribution programs should be designed in high-risk groups to reduce mortality associated with drug abuse.
Type of Study:
Research |
Subject:
General Received: 2018/06/25 | Accepted: 2018/06/25 | Published: 2018/06/25
Send email to the article author